Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
Clinical trial NCT00481143 · COMPLETED
Trial details
- NCT number
- NCT00481143
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.